We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.76B
1-Year Est. Return 62.41%
This Fund
S&P 500
This Quarter Est. Return
+3.87%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$4.81B
AUM Growth
-$531M
Cap. Flow
-$1.24B
Cap. Flow %
-25.85%
Top 10 Hldgs %
18.16%
Holding
673
New
167
Increased
91
Reduced
97
Closed
256
Avg Time Held Equity + Options
0.6 quarters
Top 10 Avg Time Held Equity + Options
0.6 quarters
Top 20 Avg Time Held Equity + Options
0.4 quarters
Avg Time Held Equity only
0.6 quarters
Top 10 Avg Time Held Equity only
0.6 quarters
Top 20 Avg Time Held Equity only
0.4 quarters

Top Buys

Rank Stock Value
1
CL icon
Colgate-Palmolive
CL
+$59.4M
2
ONXX
ONYX PHARMACEUTICALS INC
ONXX
+$56.3M
3
SPG icon
Simon Property Group
SPG
+$52M
4
TSM icon
TSMC
TSM
+$45.4M
5
M icon
Macy's
M
+$44.3M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$167M
2
GDI
GARDNER DENVER,INC
GDI
+$60.4M
3
BMC
BMC SOFTWARE, INC
BMC
+$58.7M
4
SFD icon
SMITHFIELD FOODS,INC
SFD
+$55.2M
5
AAP icon
Advance Auto Parts
AAP
+$48.2M

Sector Composition

Rank Sector Weight
1 Miscellaneous 29.53%
2 Real Estate 16.41%
3 Consumer Staples 12.46%
4 Financials 6.75%
5 Consumer Discretionary 6.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
BMC
601
DELISTED
BMC SOFTWARE, INC
BMC
– –
-1,299,351
Closed -$58.7M –
BKI
602
DELISTED
BUCKEYE TECHNOLOGY INC
BKI
– –
-64,288
Closed -$2.38M –
GDI
603
CALL
DELISTED
GARDNER DENVER,INC
GDI
– –
-196,100
Closed -$202K –
GDI
604
DELISTED
GARDNER DENVER,INC
GDI
– –
-803,005
Closed -$60.4M –
OMTH
605
DELISTED
OMTHERA PHARMACEUTICALS INC COM STK (DE)
OMTH
– –
-70,000
Closed -$931K –
TWGP
606
DELISTED
TOWER GROUP INTL LTD COM STK (BERMUDA)
TWGP
– –
-388,474
Closed -$7.97M –
ESV
607
DELISTED
Ensco Rowan plc
ESV
– –
-40,504
Closed -$9.42M –
ATVI
608
DELISTED
Activision Blizzard
ATVI
– –
-1,869,684
Closed -$26.7M –
IBTX icon
609
DELISTED
Independent Bank Group, Inc.
IBTX
– –
-193,990
Closed -$5.9M –
CELG
610
DELISTED
Celgene Corp
CELG
– –
-86,000
Closed -$5.03M –
GG
611
DELISTED
Goldcorp Inc
GG
– –
-51,039
Closed -$1.26M –
MDVN
612
DELISTED
MEDIVATION, INC.
MDVN
– –
-78,000
Closed -$1.92M –
FON
613
DELISTED
SPRINT CORP FON COM
FON
– –
-6,304,246
Closed -$44.3M –
FON
614
PUT
DELISTED
SPRINT CORP FON COM
FON
– –
-1,328,100
Closed -$3.9M –
VXX icon
615
PUT
DELISTED
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
– –
-3,203
Closed -$186K –
PACD
616
DELISTED
Pacific Drilling S A
PACD
– –
-26,263
Closed -$2.57M –
CLWR
617
PUT
DELISTED
CLEARWIRE CORP NEW CL A COM STK (DE)
CLWR
– –
-300,000
Closed -$15K –
21 22 23 24
25

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return
JCM
Janney Capital Management Pittsburgh, Pennsylvania $1.59B AUM 23.25% 1-Year Est. Return
MPM
Meritage Portfolio Management Overland Park, Kansas $1.51B AUM 26.61% 1-Year Est. Return

UBS O'Connor's Q3 2013 Portfolio in Review

As of Q3 2013, UBS O'Connor held 673 positions worth $4.81B, down 9.9% from $5.34B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

UBS O'Connor withdrew a net $1.24B in Q3 2013, closing 256 positions and reducing 97 holdings. Its most notable exit was Pfizer, an estimated $167M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 30% of assets, up from 27% a quarter earlier, followed by Real Estate and Consumer Staples.

Against the trend, UBS O'Connor opened a new position in Colgate-Palmolive worth $59.4M.

  • UBS O'Connor's largest Q3 2013 buy was Colgate-Palmolive: 1,002,498 shares worth $59.4M.
  • UBS O'Connor added most to ONYX PHARMACEUTICALS INC in Q3 2013, an estimated $56.3M increase.
  • UBS O'Connor's biggest Q3 2013 reduction was Advance Auto Parts, cutting an estimated $48.2M.
  • UBS O'Connor fully exited Pfizer in Q3 2013, selling an estimated $167M.
  • UBS O'Connor's ten largest holdings make up 18% of its $4.81B portfolio in Q3 2013.
  • UBS O'Connor opened 167 new positions and closed 256 in Q3 2013.
  • UBS O'Connor's portfolio value fell 9.9% quarter-over-quarter to $4.81B.

Based on UBS O'Connor's 13F filing for Q3 2013, filed 14 Nov 2013.